Artificial Intelligence (AI) will be utilized for the development of treatment to cure cancer.
The pharmaceutical firm GSK in partnership with King’s College London will use Artificial Intelligence (AI) to create personalized treatments for cancer as reported by Guardian. This collaboration involves the GSK’s 10 artificial intelligence experts working with the 10 oncology specialists from King’s College London. Read More